β-Hederin
| Code | Size | Price |
|---|
| TAR-T3S0205-5mg | 5mg | £270.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
1. Beta-Hederin has antileishmanial activity. 2. Beta-Hederin has apoptotic effect on breast cancer cells, it could be a promising candidate for chemotherapy of breast cancer.
CAS:
35790-95-5
Formula:
C41H66O11
Molecular Weight:
734.968
Pathway:
Microbiology/Virology
Purity:
0.98
SMILES:
C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@@H](O)CO[C@H]2O[C@H]2CC[C@@]3(C)[C@@H](CC[C@]4(C)[C@@H]3CC=C3[C@@H]5CC(C)(C)CC[C@@]5(CC[C@@]43C)C(O)=O)C2(C)C)[C@H](O)[C@H](O)[C@H]1O
Target:
Parasite
References
Greunke C , Hage-H?lsmann, Anne, Sorkalla T , et al. A systematic study on the influence of the main ingredients of an ivy leaves dry extract on the ?2-adrenergic responsiveness of human airway smooth muscle cells[J]. Pulmonary Pharmacology & Therapeutics, 2015, 31:92-98.